Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aldo-keto reductase family 1 member D1 pseudogene 1 (AKR1D1P1) is a processed pseudogene related to the enzymatically active gene AKR1D1, which encodes 3-oxo-5-beta-steroid 4-dehydrogenase. AKR1D1P1 itself lacks protein-coding potential due to sequence interruptions and is not known to produce a functional transcript or protein. Pseudogenes are generally considered non-functional remnants of genes generated by gene duplication or retrotransposition, and AKR1D1P1 is not recognized as a therapeutic target, receptor, enzyme, or participant in human disease. There is no evidence in the literature of pathological or regulatory function for this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aldo-keto reductase family 1 member D1 pseudogene 1 (AKR1D1P1).